We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Data Errors in Results and Table 2.
- Abstract
Correction In the Original Investigation titled "Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial" by Correll et al,[1] published online January 8, 2020, in the Efficacy subsection of the Results section, the multiplicity-adjusted I P i values for change from baseline to day 28 in the Positive and Negative Syndrome Scale total score vs placebo and for change from baseline to day 28 in the Clinical Global Impression-Severity of Illness were I P i =.04, not I P i =.05; this change has also been made to the corresponding data in Table 2. Furthermore, the nominal I P i values for these data were actually unadjusted. Reference 1 Correll CU, Davis RE, Weingart M. Efficacy and safety of lumateperone for treatment of schizophrenia: a randomized clinical trial [published online January 8, 2020].
- Subjects
CLINICAL trials
- Publication
JAMA Psychiatry, 2020, Vol 77, Issue 4, p438
- ISSN
2168-622X
- Publication type
journal article
- DOI
10.1001/jamapsychiatry.2020.0055